Evercore Cuts Azenta (AZTA) Price Target, Keeps Outperform Rating

Azenta, Inc. (NASDAQ:AZTA) is one of the 10 Best Medical Stocks to Buy Under $30. On April 6, Evercore ISI reduced its price target on Azenta, Inc. (NASDAQ:AZTA) from $45 to $35 while maintaining its Outperform rating on the stock. This update came as part of the firm’s first-quarter preview for the medical technology and life science tools sector.

In other news, Azenta, Inc. (NASDAQ:AZTA) announced that Trey Martin has been appointed President of its Multiomics business, effective April 6, 2026. In this new role, Martin will lead the Multiomics division and report directly to the company’s President and Chief Executive Officer, John Marotta.

Evercore Cuts Azenta (AZTA) Price Target, Keeps Outperform Rating

According to the report by Azenta, Inc. (NASDAQ:AZTA), this appointment is aimed at speeding up progress on its long-range Multiomics plan, which was outlined at the company’s Investor Day in December 2025. The plan focuses on expanding global synthesis capabilities, improving operations, strengthening commercial execution, and driving profitable growth across its integrated Multiomics platform to support performance and wider market adoption.

Meanwhile, Ginger Zhou will step down as President of the Multiomics business but will stay with the company in an advisory capacity through November 2026 to help ensure a smooth transition as the business moves into its next phase of execution.

Azenta, Inc. (NASDAQ:AZTA) is a life sciences company that offers a wide range of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry’s top pharmaceutical, biotech, academic and healthcare institutions around the world.

While we acknowledge the risk and potential of AZTA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AZTA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Fintech Stocks to Invest In According to Billionaires and 10 Unrivaled Stocks of the Next 5 Years.

Disclosure: None.  Follow Insider Monkey on Google News.